Free Trial

Kooth (KOO) Competitors

Kooth logo
GBX 177 -0.50 (-0.28%)
(As of 09:49 AM ET)

KOO vs. INS, COG, RENX, INHC, IQAI, FDBK, DVRG, TRLS, SENS, and EMIS

Should you be buying Kooth stock or one of its competitors? The main competitors of Kooth include Instem (INS), Cambridge Cognition (COG), Renalytix (RENX), Induction Healthcare Group (INHC), IQ-AI (IQAI), Feedback (FDBK), DeepVerge (DVRG), Trellus Health (TRLS), Sensyne Health (SENS), and EMIS Group (EMIS). These companies are all part of the "health information services" industry.

Kooth vs.

Instem (LON:INS) and Kooth (LON:KOO) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, community ranking, institutional ownership, analyst recommendations, profitability and media sentiment.

Kooth has lower revenue, but higher earnings than Instem. Kooth is trading at a lower price-to-earnings ratio than Instem, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Instem£61.63M3.24£3.34M£0.145,928.57
Kooth£54.17M1.19£4.28M£0.121,475.00

Instem received 83 more outperform votes than Kooth when rated by MarketBeat users. However, 90.91% of users gave Kooth an outperform vote while only 52.25% of users gave Instem an outperform vote.

CompanyUnderperformOutperform
InstemOutperform Votes
93
52.25%
Underperform Votes
85
47.75%
KoothOutperform Votes
10
90.91%
Underperform Votes
1
9.09%

In the previous week, Instem's average media sentiment score of 0.00 equaled Kooth'saverage media sentiment score.

Company Overall Sentiment
Instem Neutral
Kooth Neutral

Kooth has a net margin of 7.89% compared to Instem's net margin of 5.50%. Kooth's return on equity of 23.83% beat Instem's return on equity.

Company Net Margins Return on Equity Return on Assets
Instem5.50% 6.35% 4.62%
Kooth 7.89%23.83%10.12%

Kooth has a consensus target price of GBX 585, indicating a potential upside of 230.51%. Given Kooth's stronger consensus rating and higher possible upside, analysts plainly believe Kooth is more favorable than Instem.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Instem
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Kooth
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

65.9% of Instem shares are held by institutional investors. Comparatively, 65.0% of Kooth shares are held by institutional investors. 30.0% of Instem shares are held by company insiders. Comparatively, 17.3% of Kooth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Instem has a beta of 0.42, indicating that its stock price is 58% less volatile than the S&P 500. Comparatively, Kooth has a beta of 0.71, indicating that its stock price is 29% less volatile than the S&P 500.

Summary

Kooth beats Instem on 9 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

KOO vs. The Competition

MetricKoothHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£64.57M£220.36M£5.20B£1.43B
Dividend YieldN/A6.58%5.23%11.75%
P/E Ratio1,475.00763.9385.711,563.72
Price / Sales1.19270.351,469.42215,756.83
Price / Cash5.4237.0435.2932.90
Price / Book2.574.474.912.88
Net Income£4.28M-£5.65M£117.36M£153.02M
7 Day Performance8.39%5.34%2.75%8.95%
1 Month Performance1.72%7.67%1.71%16.98%
1 Year PerformanceN/A4.71%36.01%24.46%

Kooth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KOO
Kooth
N/AGBX 177
-0.3%
GBX 585
+230.5%
-39.9%£64.57M£54.17M1,475.00478
INS
Instem
N/AGBX 830
flat
N/A+0.0%£199.62M£61.63M5,928.57500
COG
Cambridge Cognition
N/AGBX 27.89
+2.1%
N/A-48.8%£11.70M£13.08M-687.5080Positive News
Gap Up
RENX
Renalytix
N/AGBX 6.86
-3.4%
N/A-63.2%£11.38M£2.29M-29.17102News Coverage
Gap Up
INHC
Induction Healthcare Group
N/AGBX 9.65
+7.2%
N/A-61.4%£9.06M£13.65M-300.0074Gap Up
High Trading Volume
IQAI
IQ-AI
N/AGBX 1.42
-3.7%
N/A-60.8%£3.16M£538,190.00-13.676
FDBK
Feedback
N/AGBX 19.67
-1.7%
N/A-72.7%£2.62M£1.18M-80.5424Insider Trade
News Coverage
High Trading Volume
DVRG
DeepVerge
N/AGBX 0.15
flat
N/AN/A£1.14M£12.41M-15.0073
TRLS
Trellus Health
N/AGBX 0.60
-1.0%
N/A-84.0%£969,000.00£35,000.00-20.8331
SENS
Sensyne Health
N/AGBX 0.35
-33.3%
N/A+0.0%£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AGBX 1,920
flat
N/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools


This page (LON:KOO) was last updated on 12/3/2024 by MarketBeat.com Staff
From Our Partners